Business


Posts filtered by tags: Pfizer[x]


 

Johnson & Johnson one-shot Covid vaccine gets nod from FDA advisory panel

Vaccine, along with those from Pfizer and Moderna, should provide US with more than enough supply to vaccinate every personThe battle against Covid-19 took a major step forward on Friday as the US moved closer to distributing its first one-shot Covid-19 vaccine, after an independent expert advisory panel recommended drug regulators authorize the Johnson & Johnson vaccine for emergency use.The authorization would be a significant boost to the Biden administration’s vaccination plans, making Johns...
Tags: Business, US, US news, US politics, Pharmaceuticals industry, Fda, Vaccines and immunisation, Pfizer, Johnson, Biden, Johnson Johnson, Moderna, Janssen Johnson Johnson, Biden Administration, Coronavirus, COVID


J&J's one-dose coronavirus vaccine just won a critical thumbs-up from an FDA panel, paving the way for US authorization

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images A panel of independent experts voted unanimously Friday in favor of recommending Johnson & Johnson's coronavirus vaccine.  US regulators are expected to authorize the single-dose vaccine in the coming days.  J&J has said it will be able to ship nearly 4 million doses following a regulatory OK.  Visit the B...
Tags: Health, Science, US, Trends, Healthcare, Fda, Pfizer, Johnson & Johnson, US Food and Drug Administration, EUA, Centers for Disease Control and Prevention Read, Moderna, Eric Rubin, Coronavirus, COVID, Coronavirus Vaccine


People who had COVID-19 develop strong immunity after a single vaccine dose - so they might need only one shot

A dentist receives the Moderna COVID-19 vaccine on January 8. mark Rightmire/Getty Images Two new studies suggest that people who had COVID-19 mount a stronger immune response to their first shot than those who were never infected. Other preliminary studies found that people who already had the coronavirus respond to their first shot the way other people do to their second. So it's possible some people might need only one shot to sufficiently protect them. Visit Business Insider's homepage...
Tags: UK, Science, News, Cdc, US, Los Angeles, Trends, Healthcare, Pfizer, The New York Times, Disneyland, Times, Antibodies, Centers For Disease Control And Prevention, Mount Sinai, Lax


We're on the brink of a 3rd US COVID-19 vaccine

Hello,It's snowy again here in Denver, just in time for the East Coast to get a break. My dog is loving it, and I wish I was tech-savvy enough to include videos in emails. You'll have to just imagine a 70-pound pup bounding through a foot of snow. This week, we've gotten promising news about vaccines and taken a closer look at when founder relationships fall apart and one-time kingmakers' futures become more uncertain. We also took stock of what's coming next for virtual-care providers and gene ...
Tags: Amazon, Scotland, US, Trends, Comcast, Healthcare, Cigna, Food And Drug Administration, Berkshire Hathaway, Philadelphia, Fda, Pfizer, Vaccine, East Coast, Denver, Universal Studios


A panel of scientists and doctors is reviewing J&J's one-dose coronavirus vaccine today. Here's what to watch for and how to follow along.

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images Johnson & Johnson's single-dose COVID-19 vaccine will face a crucial review Friday from an expert panel convened by the FDA. The meeting, scheduled for 9:00 a.m. ET to 5:30 p.m. ET, is expected to ultimately put J&J's shot one step closer to a regulatory OK. The FDA is live-streaming the all-day meeting on...
Tags: Health, Science, Youtube, US, Trends, Healthcare, Fda, Pfizer, Johnson & Johnson, US Food and Drug Administration, EUA, Moderna, Andrew Dunn, Coronavirus, COVID, Coronavirus Vaccine


Australia politics live: Scott Morrison and AFP reportedly told of historic rape allegation against a cabinet minister

Victoria reports two new local Covid cases; remains of missing businesswoman Melissa Caddick found; 85% of Australians likely to get vaccinated. Follow liveMelissa Caddick: remains of missing businesswoman found months after disappearanceHarvey Norman to keep $22m in jobkeeper despite profits doubling to $462m in pandemicAustralia considers relaxing temperature controls on Pfizer vaccineFollow our global coronavirus live blog 7.55am GMT Greens senator Sarah Hanson-Young has also released he...
Tags: Health, Business, Labor, Abc, Australia, Australia news, Australian politics, Queensland, New South Wales, Victoria, Pfizer, Tasmania, Scott Morrison, Norman, South Australia, Peter Dutton


Fauci urges Americans to get vaccinated, not to cherry-pick the brand they receive

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, prepares to receive his first dose of a COVID-19 vaccine at the National Institutes of Health on December 22, 2020 in Bethesda, Maryland. Patrick Semansky-Pool/Getty Images Dr. Anthony Fauci urged Americans to get vaccinated against COVID-19, but not cherry-pick the brand they receive. An FDA advisory committee is set to vote on green-lighting a coronavirus vaccine by Johnson & Johnson on Friday. "Peo...
Tags: Science, Nbc, US, Trends, Food And Drug Administration, National Institutes of Health, Fda, Pfizer, Anthony Fauci, Johnson Johnson, Fauci, Bethesda Maryland, Moderna, Hilary Brueck, Aria Bendix, Coronavirus


Biden warns Americans not to let their guards down as new COVID-19 variants spread

President Joe Biden speaks on U.S. supply chains, in the State Dining Room of the White House, Wednesday, Feb. 24, 2021, in Washington. Evan Vucci/AP President Joe Biden warned against COVID-19 complacency in the face of new variants.  Biden said that getting back to normal "depends on all of us." COVID-19 cases are on the decline and vaccinations are ramping up in a race against the variants.  Visit the Business section of Insider for more stories. President Joe Biden warned Americans aga...
Tags: Politics, Science, California, White House, New York City, US, America, Trends, Joe Biden, Atlantic, United States, United Kingdom, Fda, Pfizer, The New York Times, Biden


Biden tells Americans not to let their guards down as new COVID-19 variants spread

President Joe Biden speaks about US supply chains on February 24. Evan Vucci/AP President Joe Biden warned against COVID-19 complacency in the face of new variants.  Biden said that getting back to normal "depends on all of us." COVID-19 cases are on the decline, and vaccinations are ramping up in a race against the variants. Visit the Business section of Insider for more stories. President Joe Biden warned Americans against getting complacent about COVID-19 as the threat of new variants c...
Tags: Politics, UK, Science, California, New York City, US, America, Trends, Joe Biden, Atlantic, South Africa, Food And Drug Administration, National Institutes of Health, Pfizer, The New York Times, Biden


How the new one-dose COVID-19 vaccine compares to Pfizer and Moderna

A COVID-19 vaccine produced by Johnson & Johnson — the company best known for producing Band-Aids — is safe and effective, according to a Food and Drug Administration review released Wednesday, paving the way for a third U.S. vaccine. If approved after a Friday, Feb. 26 review by the FDA’s Vaccines and Related Biological Products Advisory Committee, the vaccine could be authorized as soon as Saturday. The company plans to begin shipping immediately. While not quite as effective as existing Pfize...
Tags: Business, News, Medicine, California, Cdc, China, US, California News, Sport, Indiana, Soccer, United States, South Africa, Food And Drug Administration, Brazil, Astrazeneca


J&J's coronavirus shot could dramatically accelerate the US vaccine rollout. Here's your new vaccination timeline.

A clinical trial volunteer participates in Johnson & Johnson's study to test a coronavirus vaccine. Janssen Johnson & Johnson's single-dose coronavirus shot could be authorized for emergency use within days. If that happens, the US could finish vaccinating priority groups in March. The US could also distribute 500 million doses by the end of June — enough to vaccinate all of its adult population. Visit the Business section of Insider for more stories. A shot for every American. Politic...
Tags: Usa, Science, News, White House, US, Trends, UPS, House, Food And Drug Administration, Fda, Pfizer, Disneyland, Centers For Disease Control And Prevention, Johnson & Johnson, Louisville Kentucky, J J


What you need to know about J&J's coronavirus vaccine

Hello,Yesterday was a big day in vaccine news. We learned more about how well Johnson & Johnson's vaccine works and how safe it is. And we also learned that Moderna has a plan for tackling variants. That includes a new shot it's sending to NIH for testing.  Here's a look at how J&J's shot compares to Pfizer's and Moderna's>>Also in healthcare news: What happened to Comcast Ventures, a onetime healthcare startup kingmaker, the companies gene therapy leaders may need to help fix safety issues, and...
Tags: Trends, Comcast, Healthcare, Npr, Pfizer, Vaccine, Nih, Universal Studios, Comcast Ventures, Johnson & Johnson, Medicare Advantage, Sarepta, Washington State Department of Health, Gene Therapy, Moderna, Roberto Machado Noa LightRocket


France admits it needs to repair the image of AstraZeneca's COVID-19 vaccine after struggling to convince people to take it

A sign in France says "all vaccinated against COVID-19" on February 8, 2021 THOMAS SAMSON/POOL/AFP via Getty Images France is embarking on an effort to persuade its people to accept the AstraZeneca COVID-19 vaccine. Regulators say the vaccine is safe and effective, but its performance data has prompted some doubts. France's president, Emmanuel Macron, was among those to disparage the vaccine in the past. Visit the Business section of Insider for more stories. France is working to fix the d...
Tags: Europe, Politics, UK, Science, France, Scotland, Germany, Israel, US, Trends, Turkey, News UK, Astrazeneca, Pfizer, Vaccine, Donald Trump


Pfizer is testing out a 3rd booster shot to bolster its COVID-19 vaccine against new variants

Pfizer will continue its COVID-19 vaccine clinical trial with the testing of third-dose booster shots. Dado Ruvic/Reuters Pfizer and BioNTech will study whether a third dose of their COVID-19 vaccine is safe and effective. The companies will offer booster shots to those who participated in their initial clinical trial. Booster shots may be necessary to keep up with the coronavirus' mutations and new variants. Visit the Business section of Insider for more stories. Pfizer and BioNTech annou...
Tags: UK, Science, US, Trends, South Africa, MMR, Food And Drug Administration, Astrazeneca, National Institutes of Health, Pfizer, Oxford University, Latin America, Mount Sinai, Reuters, Johnson Johnson, Woodward


Pfizer's COVID-19 vaccine performs just as well in the real world as it did in trials, a landmark Israeli study of more than 1 million people suggests. It was 94% effective.

Rabbi Yisrael Meir Lau receives a COVID-19 coronavirus vaccine at the Ichilov Hospital in Tel Aviv, Israel, Sunday, December 20, 2020. Ariel Schalit/AP Photo Pfizer-BioNTech's two-dose coronavirus vaccine was 94% effective at protecting against COVID-19 in a real-world study. In late-stage clinical trials before it was authorized, it was 95% effective. The new Israeli study of the Pfizer vaccine involved more than 1 million people. Visit the Business section of Insider for more stories. P...
Tags: Health, UK, Science, Israel, US, Trends, Harvard University, Healthcare, Sydney, Pfizer, Centers For Disease Control And Prevention, University of New South Wales, New England Journal of Medicine, Tel Aviv Israel, Johns Hopkins University, Ben Gurion University of the Negev


Pfizer is testing a 3rd booster shot to bolster its COVID-19 vaccine against new variants

Pfizer says it will continue its COVID-19 vaccine clinical trial with the testing of third-dose booster shots. Dado Ruvic/Reuters Pfizer and BioNTech say they'll study safety and efficacy of a third dose of their COVID-19 vaccine. The companies plan to offer booster shots to those who participated in their initial clinical trial. Booster shots may be necessary to keep up with the coronavirus' mutations and new variants. Visit the Business section of Insider for more stories. Pfizer and Bio...
Tags: UK, Science, US, Trends, South Africa, MMR, Food And Drug Administration, Astrazeneca, National Institutes of Health, Pfizer, Oxford University, Latin America, Mount Sinai, Reuters, Johnson Johnson, Woodward


Israeli bar offers free beer and shots to young people who get coronavirus vaccination

This is an automated machine translation of an article published by Business Insider in a different language. Machine translations can generate errors or inaccuracies; we will continue the work to improve these translations. You can find the original version here.The planet has begun to visualize the beginning of the end of the coronavirus pandemic with the supply of vaccines from Pfizer, Moderna, and AstraZeneca among others.However, many people are not very convinced about the effectiveness of...
Tags: Israel, Tel Aviv, Trends, Ikea, Astrazeneca, Red Cross, Pfizer, David Adom, Channel, BI International, Ichilov Hospital, Pfizer Moderna, auto-translation Spanish, International Licensed Content, Jeevan Ravindran, Yaiza García García


Global stocks rise as Fed Chair Jerome Powell confirms interest rates will remain low for longer

AP Photo/Richard Drew Global stocks gained Thursday after Jerome Powell struck a reassuring tone for central-bank policy.The Fed chairman said it could take more than three years before inflation reached the Fed's target of 2%.Yield on the 10-year US Treasury note rose to 1.4%, its highest in a year.Sign up here for our daily newsletter, 10 Things Before the Opening Bell.Global stocks rose Thursday after Federal Reserve Chairman Jerome Powell wrapped up his two-day congressional testimony ...
Tags: Asia, Hong Kong, Japan, UK, Texas, China, Germany, Global, US, Trends, Shanghai, Deutsche Bank, US Treasury, Pfizer, Brent Crude, Federal Reserve


Moderna just laid out its strategy to fight coronavirus variants and says a new shot is ready to be tested

In this Monday, July 27, 2020 file photo, a nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. Hans Pennink/AP Moderna is developing three different vaccine booster methods to protect against COVID-19 variants. Testing on one specifically designed to fight the variant that first emerged in South Africa will begin "very soon." The NIH will test the booster on a few hundred partic...
Tags: Congress, California, US, Trends, South Africa, National Institutes of Health, Fda, Pfizer, Nih, Binghamton, Moderna, Stéphane Bancel, Stephen Hoge, Bancel, National Institutes of Health and Moderna Inc, Hans Pennink AP Moderna


The more data we get, the more it seems vaccinated people aren't spreading the coronavirus

A man receives a COVID-19 vaccine at a health services center in Rehovot, Israel, on January 14, 2021. Xinhua/Gil Cohen Magen via Getty Images COVID-19 vaccines can help reduce coronavirus transmission, preliminary research shows. Multiple studies show vaccinated people have lower viral loads, which are linked to less spread. Research suggests vaccines also reduce asymptomatic infections.  Visit the Business section of Insider for more stories. Now that effective coronavirus vaccines are a...
Tags: Health, UK, Science, News, Kentucky, Israel, US, Tel Aviv, Trends, Research, Healthcare, Oxford, Fda, Pfizer, London Underground, Anthony Fauci


The supply of COVID-19 vaccines in the US is about to get a big boost, according to drug makers

Dado Ruvic/Reuters Dado Ruvic/Reuters Pfizer and Moderna have made manufacturing improvements to ramp up COVID-19 vaccine deliveries. Combined, the two companies now plan to deliver 600 million doses to the US by the end of July. Pharmaceutical executives spoke to a House subcommittee Tuesday on production and delivery goals.  Visit the Business section of Insider for more stories. Drug makers are ramping up deliveries of COVID-19 vaccines in the US, executives told the House Energy and Co...
Tags: Washington Post, US, Trends, House, Healthcare, Pfizer, Young, Johnson & Johnson, John Young, House Energy and Commerce, Pandemic, Moderna, Stephen Hoge, Herd Immunity, COVID-19, Covid-19 Vaccine


FDA releases new data on J&J's single-dose coronavirus vaccine showing it's safe and effective

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images US regulators just released detailed data on Johnson & Johnson's coronavirus vaccine. The single-dose vaccine will be reviewed on Friday by an expert panel that advises the FDA. If OK'd, J&J will ship nearly 4 million doses immediately, and plans to deliver 100 million doses by the end of June. Visit the B...
Tags: Health, Science, News, US, Trends, South Africa, Healthcare, Food And Drug Administration, Astrazeneca, Fda, Pfizer, Latin America, Johnson & Johnson, J J, Breaking, Moderna


North Korea hacked Pfizer because it wants to sell bootleg COVID vaccines on the international black market, sources say

North Korean leader Kim Jong Un at a ceremony for the 8th Congress of the Workers' Party in Pyongyang, January 14, 2021. KCNA via REUTERS North Korea wants "to decide which [vaccine] will be the easiest to bootleg and transport for the black market," said an official. The nation has a long history of counterfeiting, bootlegging, drug dealing, and arms smuggling. The dictatorship wants foreign currency. Its domestic currency is mostly worthless. Visit the Business section of Insider for...
Tags: News, Microsoft, North Korea, China, Russia, US, Trends, Iran, Syria, Kim Jong Un, Pfizer, Air Force, Lebanon, Hezbollah, Pyongyang, PLO


FDA releases new data on J&J's single-dose coronavirus vaccine, says it is safe and effective

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images US regulators just released detailed data on Johnson & Johnson's coronavirus vaccine. The single-dose vaccine will be reviewed on Friday by an expert panel that advises the FDA. If OK'd, J&J will ship nearly 4 million doses immediately, and plans to deliver 100 million doses by the end of June. Visit the B...
Tags: Health, Science, News, US, Trends, South Africa, Healthcare, Food And Drug Administration, Fda, Pfizer, Latin America, Johnson & Johnson, Novavax, Breaking, Moderna, Andrew Dunn


Johnson & Johnson’s single-shot COVID-19 vaccine found effective before FDA Review

By Anna Edney | Bloomberg Johnson & Johnson’s Covid-19 vaccine is safe and effective, U.S. regulators said, a key milestone on the path toward giving Americans access to the first such shot to work in a single dose. The vaccine was 72% effective in a U.S. clinical trial, Food and Drug Administration staff wrote in a document summarizing the company’s trial data, confirming findings J&J released earlier this month. There were no Covid-related deaths in the vaccinated group, the staff wrote. Agen...
Tags: Business, News, La, Sport, Soccer, South Africa, Food And Drug Administration, Fda, Pfizer, Johnson, Latin America, Agency, Congressional, J J, Pfizer Inc, LA County


Germany is pushing hard for people to take the AstraZeneca COVID-19 vaccine as many turn it down in hope of a Pfizer shot

German Chancellor Angela Merkel speaking to the media in Berlin on February 1, 2021. Henning Schacht - Pool/Getty Images Germany is enhancing its efforts to tell people the AstraZeneca COVID-19 vaccine is safe and effective. The German vaccine rollout has been complicated by people avoiding that jab. It appears to be part of a trend, reported by Insider, of trying to get the Pfizer shot instead. Visit the Business section of Insider for more stories. Officials in Germany are defending the ...
Tags: Science, Sweden, France, Germany, Angela Merkel, Berlin, Trends, News UK, European Commission, Merkel, Astrazeneca, Pfizer, Vaccine, Cdu, Reuters, Handelsblatt


One simple chart shows how well J&J's single-dose coronavirus vaccine works, with protection starting after 2 weeks

Johnson & Johnson's coronavirus vaccine is delivered as a single shot, while both Pfizer and Moderna's require two jabs. Thiago Prudêncio/SOPA Images/LightRocket via Getty Images A third US-authorized coronavirus vaccine is closer than ever.  Johnson & Johnson's single-dose shot was safe and effective at preventing COVID-19, US regulators said. One chart from the FDA's review shows how well the vaccine works, with protection coming after two weeks. Visit the Business section of Ins...
Tags: Health, Science, US, Trends, Getty Images, Healthcare, Food And Drug Administration, Fda, Pfizer, Johnson & Johnson, J J, Moderna, Andrew Dunn, Coronavirus, COVID, Coronavirus Vaccine


COVID: Vaccine makers say the supply surge is coming

By Michael Erman and Manojna Maddipatla | Reuters NEW YORK – COVID-19 vaccine makers told Congress on Tuesday that U.S. supplies should surge in the coming weeks due to manufacturing expansions and new vaccine authorizations. Executives from Pfizer Inc, Moderna Inc and Johnson & Johnson – speaking at a hearing at the U.S. House of Representatives – said they would be able to supply enough vaccine to fully inoculate 130 million people in the United States by the end of March. The drugmakers also ...
Tags: Business, Politics, News, Congress, Sport, Soccer, United States, Astrazeneca, Pfizer, Young, Reuters, U S Food and Drug Administration, Johnson Johnson, U S House of Representatives, Novavax Inc, AstraZeneca PLC


Masks will be needed until at least 2022 'for the safety of the nation,' says CVS chief

Dr. Anthony Fauci wearing face masks. Tasos Katopodis/Getty Images CVS Chief Executive Officer Karen Lynch says masks may be need until at least next year. Lynch says US is on its way to meeting goal of vaccinating 300 million Americans by end of summer. Fauci said Americans may still be wearing masks next year, depending on vaccination and case levels. Visit the Business section of Insider for more stories. Face masks will likely to be the norm until at least 2022, CVS Health CEO Karen Ly...
Tags: News, US, Trends, Joe Biden, Healthcare, Retail, Pfizer, Biden, Anthony Fauci, Cvs, Lynch, Fauci, Moderna, Facemasks, Karen Lynch, Tasos Katopodis Getty


Scotland's vaccine rollout suggests delaying the 2nd COVID-19 shot is a bad idea

A frontline healthcare worker receives a Moderna COVID-19 vaccination at the Park County Health Departments storefront clinic on January 5, 2021 in Livingston, Montana. Photo by William Campbell/Getty Images The UK strategy to delay the second coronavirus vaccine dose for up to 12 weeks carries real risk. New data from Scotland showed protection against hospitalization peaking after five weeks — and then declining. Vaccine developers and public-health experts told Insider it's a mistake to...
Tags: Health, UK, Science, News, Obama, Scotland, Israel, Trends, Healthcare, Astrazeneca, Philadelphia, Pfizer, Children s Hospital, Patel, Paul Offit, Livingston Montana



Filters
show more filters
December - 2020
MoTuWeThFrSaSu
 123456
78910111213
14151617181920
21222324252627
28293031   
January - 2021
MoTuWeThFrSaSu
    123
45678910
11121314151617
18192021222324
25262728293031
February - 2021
MoTuWeThFrSaSu
1234567
891011121314
15161718192021
22232425262728